Skip to main content
GeneBioTechCo.,Ltd. logo

GeneBioTechCo.,Ltd. — Investor Relations & Filings

Ticker · 086060 ISIN · KR7086060001 KO Manufacturing
Open in API
Filings indexed 120 across all filing types
Latest filing 2020-04-27 Regulatory Filings
Country KR South Korea
Listing KO 086060

About GeneBioTechCo.,Ltd.

http://www.gbtkorea.com

GeneBioTechCo.,Ltd., operating as GBTKOREA, is a specialized manufacturer of core components for medical X-ray imaging systems. Established in 2002, the company focuses on the design and production of high-frequency X-ray generators and related electronic systems. It provides comprehensive Original Equipment Manufacturer (OEM) customization services, developing tailored solutions for clients in the global medical equipment industry.

Recent filings

Filing Released Lang Actions
타인에대한담보제공결정(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Jinbiotech) regarding a decision to provide collateral for a third party (a subsidiary). This type of disclosure, which involves financial guarantees or collateral arrangements, does not fit into specific categories like earnings releases or annual reports. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate disclosure.
2020-04-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by Korea Securities Finance Corp in JinBioTech. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant share ownership levels.
2020-04-10 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 96% confidence The document is a formal 'Audit Report' (감사보고서) for Jinbiotech Co., Ltd. for the fiscal year ending December 31, 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is a formal audit report rather than a full 10-K annual report or a simple earnings release. Therefore, it is classified as an Audit Report. FY 2019
2020-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and the appointment of auditors. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2020-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It provides the auditor's opinion (적정 - unqualified), key financial data (assets, liabilities, equity, profit/loss), and confirms the receipt of the audit report. While it contains financial data, it is a regulatory filing announcing the submission of the audit results rather than the full annual report itself. Therefore, it fits the 'Audit Report / Information' category as it provides the core audit findings and financial summary. FY 2019
2020-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GeneBiotech Co., Ltd. It contains the agenda for the 20th Annual General Meeting, including the approval of financial statements, appointment of auditors, and director remuneration. It also includes detailed financial statements (balance sheet and income statement) as part of the 'Management Reference Materials' (경영참고사항) required for shareholder review prior to the meeting. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and the items to be voted upon.
2020-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.